Recalls & Warnings April 11, 2015 FDA Warns Maker of "Relaxation" Drink On March 4, 2015, the FDA issued a warning letter to Bebida Beverage Company (BeBevCo) following a review of the company's website and product label, which found the "relaxation beverage"Koma Unwind Liquid Relaxation to be adulterated because it contains melatonin
Safety Considerations for GLP-1 Use During Hormone Therapy GLP-1 receptor agonists like tirzepatide produce side effects related to gastrointestinal functionnausea, vomiting, constipation, and reduced appetitebut these are distinct from hormonal or estrogenic effects
At we see the use of well-tolerated biomimentic therapies like during drug holiday phases or as a long-term strategy for those who cannot continue with GLP-1s
Juhasz, C., Hu, J., Xuan, Y
doi: 10.1186/s12199-017-0677-9
D.ChengY.LiaoW